Skip to main content
Molecules logoLink to Molecules
. 2023 Nov 22;28(23):7710. doi: 10.3390/molecules28237710

Effect of Gamma Irradiation on Cannabinoid, Terpene, and Moisture Content of Cannabis Biomass

Chandrani G Majumdar 1, Mahmoud A ElSohly 1,2, Elsayed A Ibrahim 1,3, Mostafa A Elhendawy 4,5, Donald Stanford 1, Suman Chandra 1, Amira S Wanas 1, Mohamed M Radwan 1,*
Editors: Gavino Sanna, Arjun H Banskota
PMCID: PMC10707833  PMID: 38067441

Abstract

In recent years, cannabis has been proposed and promoted not only as a medicine for the treatment of a variety of illnesses, but also as an industrial crop for different purposes. Being an agricultural product, cannabis inflorescences may be contaminated by environmental pathogens at high concentrations, which might cause health problems if not controlled. Therefore, limits have to be placed on the levels of aerobic bacteria as well as yeast and mold. To ensure the safety of cannabis plant material and related products, a remediation process has to be put in place. Gamma irradiation is a sterilization process mainly used for pharmaceuticals, foods, cosmetics, agricultural, and herbal products including cannabis plant material. This study was designed to determine the effect of irradiation on the microbial count as well as on the chemical and physical profiles of the cannabis biomass, particularly cannabinoids, terpenes, and moisture content. The full cannabinoid profile was measured by GC/FID and HPLC analysis, while terpene profile and moisture content were determined using GC/MS and Loss on Drying (LoD) methods, respectively. Analyses were conducted on the samples before and after gamma irradiation. The results showed that the minimum and maximum doses were 15 and 20.8 KiloGray (KGY), respectively. Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) were determined. The study showed that irradiation has no effect on the cannabinoids and little effect on terpenes and moisture content, but it did result in the virtual sterilization of the plant material, as evidenced by the low levels of bacterial and fungal colony-forming units (CFUs) < 10 after gamma irradiation.

Keywords: cannabis, gamma irradiation, cannabinoids, terpenes, moisture content

1. Introduction

Cannabis (Cannabis sativa L.) is an annual flowering plant indigenous to Central Asia and has a rich and a fascinating recorded history [1]. Cannabis has played a significant role in many cultures for recreational and medicinal purposes and as a source of industrial fibers [2].

The dried resinous flowering buds of the cannabis plant are commonly known as “marijuana” [3].

In recent years, research on hemp has been progressively growing due to its use in various products, such as composites, plastics, and lubricants. Hemp has been used to produce textiles and fiber, in building materials like hempcrete and as a source of biofuel. Furthermore, hemp seeds can serve as a rich source of nutrition in different food products [4,5,6,7,8,9].

Cannabis contains hundreds of secondary metabolites, mainly cannabinoids, in addition to phenolic compounds, mono- and sesquiterpenoids, flavonoids, and alkaloids [10]. The unique chemicals (cannabinoids) include different types and concentrations, particularly THC, which is the main psychotropic cannabinoid and is responsible for the plant’s mind-altering effects [11]. Other cannabinoids including cannabidiol (CBD), cannabigerol (CBG), cannabichromene (CBC), and other minor compounds have comparable therapeutic benefits to THC without its side effects, as these cannabinoids could be used in the treatment of glaucoma, chronic musculoskeletal pain, spasm, nausea, spasticity of multiple sclerosis, and many others [12,13,14]. Cannabis can be divided into three main chemotypes, namely THC-dominant (type I), THC/CBD intermediate (type II), and CBD-dominant (type III) [15].

As an agricultural product, cannabis can be exposed to contamination with pathogenic fungi, bacteria, yeast, and mold during growing, drying, packing, and/or delivery, which may put consumers at health risk [16,17]. Fatal pulmonary Aspergillosis has been reported in some immunocompromised patients treated with inhaled marijuana [18,19]. Also, multistate outbreak enteritis caused by Salmonella muenchen has been reported [20]. Furthermore, Clostridium botulinum has been identified in some cannabis extracts [21].

Since cannabis legalization has progressed dramatically in recent years, and several cannabis-based products are now flooding the US market, contaminated cannabis may be found among these products, rendering them unsafe for consumers [22].

Although the federal government in the United States still considers cannabis illegal [23], nineteen U.S. states have legalized marijuana for recreational use [24]. Furthermore, a total of 37 states, three territories, and the District of Columbia allow cannabis products to be used medically [25].

Recently, the United States Food and Drug Administration (FDA) published guidance on cannabis and cannabis-derived products in which it is recommended that these products should be regulated by the same standards as any other botanical raw material, botanical drug substance, or botanical drug product [26]. In addition, many states provide their own guidelines to protect cannabis consumers for either medicinal, recreational, or both purposes [27]. Consequently, cannabis and cannabis-based products have to be free from contaminants—pesticides, microbes, molds, bacteria, heavy metals, and solvents—to protect the safety of cannabis consumers.

Several approved technologies are commonly used to reduce microbial contamination in foods and pharmaceutical products, including ethylene oxide gas, gamma irradiation, and X-ray irradiation [28]. Gamma irradiation remains the recommended method for decontaminating herbal products including cannabis [29]. However, in addition to gamma irradiation, other sterilization methods have been employed in the decontamination of medical cannabis such as beta irradiation (e-beam) and cold plasma [30].

Gamma irradiation is a form of electromagnetic energy that kills microorganisms throughout a product and its packaging. This technology, which offers deep penetration at low dose rates, was chosen as the most suitable for treating the multiple lots of National Institute on Drug Abuse (NIDA) and Drug Supply Program (DSP) plant material, as each lot varies somewhat in density and quantity. This treatment has little temperature effect on the product [31,32]. A given dose of gamma radiation takes time to deliver and, depending on the thickness and volume of the product, it may take minutes to hours [33]. The dose of gamma irradiation delivered to a packaged product unit is expressed in Kilo gray (KGY), the standard unit of measurement of ionizing radiation [28]. The irradiation process has been used commercially for more than forty years. To be effective, gamma irradiation needs time, contact, and temperature. The effectiveness of gamma irradiation is also dependent on the type of microorganism present [32]. Irradiation helps to reduce post-harvest losses through suppressing sprouting and contamination and enabling the eradication or control of insect pests, reductions in food-borne diseases, and the extension of shelf lives [34,35].

Gamma irradiation is used in the cannabis industry to develop biomass and products that are safe to consumers. With cannabis containing various types of bioactive phytochemicals including cannabinoids and terpenes (plus others) [36], it is important to ascertain the effect of gamma irradiation on these constituents.

According to the United States Pharmacopeia (USP), methods and specifications for the absence of Salmonella spp. and Escherichia coli are included in general chapter <62>, Microbiological Examination of Nonsterile Products. Meanwhile, the USP general chapter <61> includes the methods for enumerating total aerobic bacterial count and the total yeasts and molds count [37]. The Cannabis Expert Panel recommended specifications for the microbial quality control of cannabis plant material. The total aerobic bacterial count should be NMT 105 CFU/g, and the total combined mold and yeast count should be NMT 104 CFU/g, in addition to the absence of Salmonella spp. and Escherichia coli [38].

In this work, we aimed to determine the effect of irradiation on the microbial content (bacterial and fungal) and on the chemical and physical profile of the cannabis biomass, particularly the cannabinoids content, terpenes, and moisture content. Moreover, this study explores the effects of gamma irradiation on cannabis biomass, as this specific aspect of gamma irradiation’s effect on the major cannabinoids and terpenes may not have been extensively studied before compared to the previously published studies. Furthermore, testing the impact of gamma irradiation on moisture content in cannabis biomass may give an idea of the storage conditions of cannabis products, which represents an important area for the cannabis industry.

2. Results and Discussion

More than 2000 kg of cannabis plant material in 150 barrels was subjected to gamma irradiation to lower its microbial burden since these plant materials can be used in human clinical trials that might include immunocompromised subjects. All dosimetry results were in the range of 15.0 to 20.8 KGY (target range 10 to 30 KGY).

2.1. Microbial Decontamination Test Results

The microbial loads of three samples of cannabis plant material before and after gamma irradiation are displayed in Table 1. The Total Yeast and Mold Count (TYMC) was reduced from 13,000, 10,050, and 4500 CFU/g to less than 100 CFU/g, and the bacterial load (Total Aerobic Microbial Count (TAMC)) was also significantly reduced to less than 100 CFU/g by the gamma irradiation treatment. Although neither E. coli nor Salmonella spp. were detected in any lot before or after the irradiation treatment, these tests were included in the study because these tests are common in cannabis quality testing protocols.

Table 1.

Microbial test results, before and after irradiation treatment for three representative samples expressed as CFU/g.

TYMC (CFU/g) TAMC (CFU/g) E. coli and Salmonella spp.
Sample # Before Irradiation After
Irradiation
Before Irradiation After
Irradiation
Before Irradiation After
Irradiation
CS-464 13,000 <10 * 1000 No growth Absent/g Absent/g
CS-481 10,050 <100 * 4100 <100 Absent/g Absent/g
CS-483 4500 <100 * 3950 <100 Absent/g Absent/g

CFU/g = colony-forming unit per gram. * Significant (p < 0.05). TYMC = Total Yeast and Mold Count. TAMC = Total Aerobic Microbial Count. # = number.

2.2. Cannabinoid Acid Content

The concentrations of eleven cannabinoids (neutral and acid) including Δ9-THC, Δ9-THCA, CBD, CBDA, CBG, CBGA, Δ8-THC, CBN, CBC, CBCA, and THCV as % w/w were determined using our previously reported HPLC method [39].

The cannabinoid content before and after the gamma irradiation treatment of a representative sample (#CS-445) is illustrated in Figure 1. No significant change (p > 0.05) in any of the cannabinoid concentrations was evident in any of the materials before and after irradiation. Δ8-THC was not detected before and after the irradiation of the THC/CBD cannabis chemovar.

Figure 1.

Figure 1

Cannabinoid content (% w/w) of a representative sample (# CS-445) of THC/CBD cannabis chemovar (before and after gamma irradiation using HPLC).

2.3. Total Cannabinoid Content

The results in Figure 2 and Table 2 show the THC and CBD concentrations for various cannabis batches of all three chemovars (high THC, high CBD, and THC/CBD chemovars), before and after the irradiation treatment. The total cannabinoid content was determined using our previously published method [40].

Figure 2.

Figure 2

Cannabinoid content (% w/w) of (A)THC in high THC chemovar, (B) CBD in high CBD chemovar, and (C) THC and CBD in THC/CBD chemovar before and after gamma irradiation using GC/FID.

Table 2.

Cannabinoid and moisture content (%w/w) of different cannabis chemovars after and before gamma irradiation (analyzed by GC/FID).

Sample # Variety CBD * Δ9-THC * CBN THCV CBC CBG Moisture Content
B A B A B A B A B A B A B A
CS-326 THC/CBD Chemovar 5.97 ± 0.13 6.42 ± 0.16 3.64 ± 0.20 3.85 ± 0.45 0.29 0.33 0.04 0.04 0.28 0.31 0.36 0.40 7.73 8.03
CS-363 6.57 ± 0.45 6.49 ± 0.19 3.95 ± 0.11 3.85 ± 0.25 0.26 0.28 0.03 0.03 0.31 0.31 0.28 0.28 7.93 7.90
CS-445 4.65 ± 0.16 5.23 ± 0.16 2.82 ± 0.12 3.07 ± 0.20 0.24 0.23 0.03 0.03 0.25 0.21 0.29 0.25 8.05 8.22
CS-447 4.54 ± 0.16 3.96 ± 0.23 2.67 ± 0.18 2.27 ± 0.10 0.20 0.19 ND ND 0.21 0.18 0.21 0.18 8.28 8.37
CS-463 5.32 ± 0.17 5.73 ± 0.16 2.73 ± 0.17 2.85 ± 0.06 0.37 0.43 ND ND 0.23 0.25 0.22 0.24 8.1 8.23
CS-464 4.61 ± 0.27 5.03 ± 0.01 2.38 ± 0.10 2.48 ± 0.27 0.34 0.43 ND ND 0.18 0.26 0.31 0.28 8.01 7.65
CS-465 4.75 ± 0.17 4.13 ± 0.08 1.97 ± 0.12 1.60 ± 0.10 0.40 0.35 ND ND 0.20 0.18 0.21 0.18 8.14 8.47
CS-466 3.58 ± 0.15 4.12 ± 0.09 1.73 ± 0.15 1.94 ± 0.14 0.22 0.27 ND ND 0.17 0.14 0.27 0.25 8.45 8.55
CS-467 3.43 ± 0.17 3.77 ± 0.08 1.25 ± 0.18 1.39 ± 0.11 0.25 0.28 ND ND 0.16 0.13 0.11 0.11 8.18 8.10
CS-370 High CBD Chemovar 3.79 ± 0.12 4.06 ± 0.10 0.10 ± 0.08 0.11 ± 0.07 ND ND ND ND 0.12 0.13 0.07 0.08 7.82 8.11
CS-437 3.86 ± 0.32 3.75 ± 0.30 0.18 ± 0.12 0.16 ± 0.09 0.02 0.01 ND ND 0.14 0.16 0.14 0.16 8.66 8.35
CS-438 3.70 ± 0.04 4.00 ± 0.22 0.12 ± 0.10 0.12 ± 0.03 0.07 0.08 ND ND 0.14 0.14 0.07 0.08 8.94 8.27
CS-459 10.96 ± 0.06 11.14 ± 0.45 0.39 ± 0.14 0.36 ± 0.03 0.06 0.05 0.03 0.03 0.36 0.36 0.32 0.29 8.04 8.12
CS-460 5.89 ± 0.05 6.22 ± 0.12 0.20 ± 0.15 0.18 ± 0.08 ND ND ND ND 0.21 0.25 0.15 0.16 7.77 7.90
CS-461 5.74 ± 0.12 5.71 ± 0.05 0.16 ± 0.11 0.15 ± 0.04 ND ND ND ND 0.20 0.20 0.12 0.12 7.75 8.05
CS-468 3.00 ± 0.12 3.17 ± 0.02 0.86 ± 0.16 0.87 ± 0.07 0.20 0.21 ND ND 0.11 0.12 0.11 0.11 8.61 9.34
CS-481 4.70 ± 0.11 5.49 ± 0.07 0.35 ± 0.17 0.37 ± 0.08 0.03 0.03 0.01 0.01 0.24 0.27 0.12 0.14 8.00 8.16
CS-483 5.26 ± 0.13 5.44 ± 0.04 0.10 ± 0.08 0.10 ± 0.02 0.14 0.16 0.01 0.01 0.31 0.30 0.25 0.24 6.41 6.40
CS-506 4.50 ± 0.08 4.37 ± 0.02 0.20 ± 0.11 0.20 ± 0.01 0.03 0.04 0.01 0.01 0.30 0.24 0.09 0.08 5.64 6.28
CS-317 High THC Chemovar 0.09 ± 0.01 ND 5.61 ± 0.30 6.08 ± 0.44 0.16 0.23 0.04 0.04 0.10 0.10 0.08 0.10 10.47 10.18
CS-441 0.15 ± 0.04 0.16 ± 0.08 6.49 ± 0.16 7.52 ± 0.16 0.52 0.54 0.04 0.05 0.31 0.33 0.16 0.18 8.74 8.26
CS-442 0.06 ± 0.01 0.06 ± 0.01 6.58 ± 0.50 7.02 ± 0.28 0.53 0.64 0.07 0.07 0.28 0.32 0.13 0.19 7.28 7.65
CS-469 ND ND 6.54 ± 0.18 6.60 ± 0.31 0.66 0.60 0.09 0.07 0.20 0.19 0.21 0.23 8.43 8.65
CS-471 ND ND 6.12 ± 0.34 6.62 ± 0.12 0.54 0.57 0.05 0.04 0.19 0.16 0.18 0.17 7.44 8.14
CS-472 ND ND 7.39 ± 0.10 5.97 ± 0.02 0.70 0.66 0.05 0.04 0.26 0.23 0.28 0.23 8.51 8.04
CS-473 ND ND 5.49 ± 0.04 5.45 ± 0.12 0.52 0.58 0.04 0.04 0.22 0.19 0.16 0.16 7.97 7.95
CS-474 ND ND 4.97 ± 0.05 5.24 ± 0.02 0.49 0.58 0.03 0.03 0.18 0.19 0.14 0.15 7.92 8.13
CS-475 ND ND 5.78 ± 0.15 5.87 ± 0.09 0.50 0.55 0.04 0.04 0.21 0.20 0.17 0.18 8.44 8.01
CS-476 ND ND 3.40 ± 0.18 3.91 ± 0.05 0.46 0.44 ND ND 0.16 0.18 0.11 0.13 7.32 7.30
CS-477 ND ND 6.01 ± 0.13 5.22 ± 0.10 0.57 0.55 0.05 0.04 0.22 0.19 0.18 0.16 7.9 7.52
CS-478 ND ND 2.42 ± 0.07 2.63 ± 0.15 0.27 0.31 ND ND 0.15 0.15 0.06 0.07 7.56 7.87
CS-479 ND ND 2.22 ± 0.06 2.50 ± 0.09 0.28 0.35 ND ND 0.16 0.19 0.06 0.06 7.85 7.85
CS-480 0.05 ± 0.01 0.05 ± 0.04 1.44 ± 0.14 1.32 ± 0.03 0.44 0.39 0.04 0.04 0.13 0.15 0.04 0.04 7.58 7.81

# = number. B = before irradiation, A = after irradiation, ND = not detected, Δ8-THC was not detected in any sample. * Concentration % w/w ± standard error.

As demonstrated in Table 3, a paired t-test was employed to assess the variations in total cannabinoid concentrations within the samples before and after irradiation. The results indicate that there were no statistically significant changes, as all calculated p-values exceeded the 0.05 significance threshold (Table 3).

Table 3.

Paired sample t-test of total cannabinoids in cannabis samples analyzed by GC/FID.

Before
Irradiation
After
Irradiation
t df p-Value
CS-326B CS-326A −2.354 6 0.057
CS-363B CS-363A 1.571 6 0.167
CS-445B CS-445A −1.506 6 0.183
CS-447B CS-447A 1.475 5 0.200
CS-463B CS-463A −2.116 5 0.088
CS-464B CS-464A −0.487 5 0.647
CS-465B CS-465A 0.946 5 0.388
CS-466B CS-466A −1.621 5 0.166
CS-467B CS-467A −1.069 5 0.334
CS-370B CS-370A −1.782 4 0.149
CS-437B CS-437A 1.286 4 0.268
CS-438B CS-438A 0.444 5 0.676
CS-459B CS-459A −0.933 6 0.387
CS-460B CS-460A −1.551 4 0.196
CS-461B CS-461A −0.835 4 0.450
CS-468B CS-468A −1.313 5 0.246
CS-481B CS-481A −1.332 6 0.231
CS-483B CS-483A −0.925 6 0.391
CS-506B CS-506A −0.658 6 0.535
CS-317B CS-317A −0.451 5 0.671
CS-441B CS-441A −0.525 6 0.619
CS-442B CS-442A −2.116 6 0.079
CS-469B CS-469A −0.865 5 0.427
CS-471B CS-471A −1.508 5 0.192
CS-472B CS-472A 1.475 5 0.200
CS-473B CS-473A 0.344 5 0.745
CS-474B CS-474A −2.076 5 0.092
CS-475B CS-475A 0.621 5 0.562
CS-476B CS-476A −0.996 4 0.376
CS-477B CS-477A 1.598 5 0.171
CS-478B CS-478A −1.838 4 0.140
CS-479B CS-479A −1.445 4 0.222
CS-480B CS-480A −0.281 6 0.788

2.4. Terpene Content

The quantitative analysis of terpenes was performed by GC/MS [41]. For a representative sample (#CS173, Figure 3), a paired t-test was utilized to evaluate the changes in terpene concentrations before and after irradiation. The analysis shows a p-value of 0.13, indicating that no statistically significant alteration in terpene concentration was observed within the sample, confirming the results of a previous study [29]. All samples were analyzed in triplicate.

Figure 3.

Figure 3

Terpene content (ppm) in a representative sample of high THC chemovar (sample #CS317) before and after gamma irradiation.

2.5. Moisture Content

Among measurement standards for foodstuffs and agricultural products, Loss on Drying continues to be the most widely used method for moisture content [38]. The technical simplicity of the technique probably accounts for its popularity [38]. The results of moisture content are illustrated in Table 2.

The moisture content was calculated from the following equation:

Moisture%=MbMaMb×100

where Mb and Ma are the mass of the sample before and after drying, respectively. The difference denotes the moisture content of the sample. From the results, no significant change (p > 0.05) in the moisture content of any of the samples was observed due to the irradiation treatment (Table 3).

3. Materials and Methods

3.1. Cannabis Plant Material

Cannabis plants were grown in the field at the University of Mississippi, United States of America. Female cuttings of screened and selected high-yielding chemovars (high THC, THC/CBD, and high CBD) were grown indoors in four-inch biodegradable jiffy pots. Well-rooted cuttings were then transferred to an outdoor field for further growth. At maturity, plants were harvested, dried (for 24 h at 40 °C in a ventilated oven), processed, and stored in FDA-approved barrels. These barrels were stored at 25 °C for future use. Samples were taken from each barrel and ground in a stainless-steel coffee grinder and used for subsequent analyses.

3.2. Gamma Irradiation Treatment Procedures

Sterigenics is a contract sterilization company that operates a gamma irradiation facility located in West Memphis, Arkansas, 145 km from the National Center of Natural Products Research (NCNPR), at the University of Mississippi. The facility normally operates continuously, receiving commercial products in large shipments trucked to the facility for treatment. The Drug Enforcement Agency (DEA) Schedule-I control status of most of the DSP materials required special handling and security measures for the treatment, including authorizations by DEA, the National Institute on Drug Abuse (NIDA), and the Arkansas State Board of Pharmacy. The materials were transported in a cargo truck with security escorts.

The Sterigenics facility uses a hanging tote irradiator system with eighteen Cobalt-60 source stations. Each tote can accommodate products in packages of up to 30′ × 24′ × 40′ dimensions and 23 kg in weight. To prepare the packaged materials to fit the totes, the polyethylene bags containing the plant material were transferred to appropriate-size cardboard boxes before transportation to the facility. At the facility, a dosimeter was attached to each box which was then loaded onto a tote. The totes were carried by a conveyor system through a radiation shield into the irradiation chamber where they passed by the source stations following a serpentine route to expose all sides of the boxes to the gamma rays. The target dose for each box was specified to be in the range of 10 to 30 KGY based on recommendations by Sterigenics specialists. When the totes carrying the boxes exited the irradiation chamber after several hours of treatment, each dosimeter was read to verify that each box had received the specified dose.

3.2.1. NIDA DSP Materials Currently Treated

As of August 2020, all the DSP plant material supplies stocked at NCNPR have undergone gamma irradiation treatment. A total of 2016 kg of plant material in 150 different barrel lots was treated on three different occasions.

3.2.2. Microbial Contamination

Microbial testing was performed in duplicate following USP <61> and <62> procedures for Total Yeast and Mold Count (TYMC), Total Aerobic Microbial Count (TAMC), E. coli, and Salmonella spp. [38].

3.2.3. Treatment Study

In order to measure the effect of gamma irradiation treatment on the chemical and physical characteristics of cannabis plant material, thirty-three barrel lots of the three cannabis chemovars were analyzed at NCNPR before and after the treatment for cannabinoids, terpenes, and moisture content. In order to verify the effectiveness of the treatment in reducing microbial contaminants, three barrel lots were tested for microbes before and after the treatment.

3.2.4. Dose Verification

A scintillation counter was used to measure the exposure of each dosimeter to verify that each box had received the specified dose.

3.3. Cannabinoid and Terpene Standards

Cannabidiol (CBD), Cannabidiolic acid (CBDA), trans9-tetrahydrocannabinol (Δ9-THC), trans9-tetrahydrocannabinolic acid A (THCAA), Cannabigerol (CBG), Cannabigerolic acid (CBGA), trans8-tetrahydrocannabinol (Δ8-THC), cannabichromene (CBC), cannabinol (CBN), and trans9-tetrahydrocannabivarin (THCV) were isolated from different cannabis varieties at the University of Mississippi. Cannabichromic acid (CBCA) was purchased from Cayman® (Ann Arbor, MI, USA). All cannabinoid standards were checked for their purity by GC/MS and HPLC (purity ≥ 99%). Terpene standards—α-pinene, β-pinene, β-myrcene, d-limonene, terpinolene, linalool, terpineol, β-caryophyllene, α-humulene, and caryophyllene oxide—were purchased from Sigma-Aldrich® (Burlington, MA, USA). The purity of all standards was checked by GC-MS and found to be ≥ 90%, except terpinolene, which was ≥85%. n-tridecane (purity ≥ 99%) was used as the internal standard and purchased from Sigma-Aldrich®.

The chemical structures of the tested cannabinoids and terpenes are shown in Figure 4.

Figure 4.

Figure 4

(A) Chemical structures of the tested cannabinoids and (B) terpenes.

3.4. Solvents and Reagents

The solvents including MeOH, ACN, and EtOAc were of HPLC grade and purchased from Fisher Scientific® (Waltham, MA, USA). Chloroform was of analytical grade and purchased from Sigma-Aldrich®.

3.5. Determination of Total Cannabinoids Using GC-FID

The method used by NCNPR for the routine analysis of cannabinoids uses a gas chromatograph with a flame ionization detector (GC/FID) to quantitate seven different cannabinoids: Δ9-tetrahydrocannabinol (Δ9-THC), Δ8-tetrahydrocannabinol (Δ8-THC), cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV), cannabichromene (CBC), and cannabigerol (CBG) [40]. All 33 barrel lots were tested by this validated method which directly determines the “total cannabinoid” profile which reflects the cannabinoid amounts available to a person through smoking. All samples were analyzed in triplicate.

GC analyses were performed using a Varian CP-3380 gas chromatograph equipped with Varian CP-8400 automatic liquid samplers, capillary injectors, and dual-flame ionization detectors. The analysis was carried out using a DB-1MS column (15 m × 0.25 mm I.D., 0.25 µm film thickness; Agilent, Santa Clara, CA, USA). Data were acquired using a Dell Optiplex GX1 computer and Varian Star workstation software (version 6.1). Helium was used as the carrier and detector makeup gas at a flow rate of 1 mL/min with an upstream split ratio of 50:1. The injector temperature and the detector temperature were 240 °C and 270 °C, respectively. The temperature program was 170 °C (hold 1 min) to 250 °C at 10 °C/min (hold 3 min); run time, 12 min; injection volume, 1 µL. The instrument was calibrated daily to ensure a Δ9-THC/internal standard response factor ratio of one.

Calculation of Concentrations

The concentration of a specific cannabinoid was calculated as follows:

Cannabinoid%=Area of the analyteArea of IS×Amount of ISAmount of sample×100

In order to remove seeds and stems, the samples were manicured in a 14-mesh metal sieve. Triplicate samples (100 mg) were extracted with internal standard solution (IS) (3 mL, 4-androstene-3,17-dione in chloroform: methanol (100 mL, 1:9, v/v), 1 mg/mL) at room temperature for 1 h. The extracts were filtered through a cotton plug and then transferred to GC vials, ready for analysis. An aliquot of 1 μL was injected into the GC/FID.

3.6. Quantitative Analysis of Cannabinoid Acids Using HPLC-PDA

Cannabis samples were analyzed for both the free and acid forms of cannabinoids using a high-performance liquid chromatograph equipped with a photodiode array detector (HPLC/PDA), and eleven different cannabinoids were quantitated according to our validated method [39]. All samples were analyzed in triplicate. The chromatographic conditions are shown in Table 4.

Table 4.

HPLC/PDA conditions for the analysis of cannabinoid acids.

Parameter Description
HPLC instrument Waters Alliance 2695e HPLC system with a binary HPLC pump and a Waters 2996 PDA detector.
Column and guard column Luna C18(2) column (150 × 4.60 mm, 3 µm; Phenomenex, Torrance, CA) equipped with a C18 guard column cartridge (Phenomenex).
Mobile phase of 0.1% (v/v) formic acid in water (mobile phase A) and 0.1% (v/v) formic acid in acetonitrile (mobile phase B) according to a gradient elution started at 70% B from 0 to 6 min; then 77% B in 6 min; kept 77% B for 10 min; afterwards, the system was returned to the initial conditions with a total run time of 22.2 min.
Flow rate 1.2 mL/min.
Injection volume 10 µL.
PDA wavelength 220 nm.
Software Empower 3 software.

Manicured plant samples (50 mg each) were weighed into glass scintillation vials and extracted each with 10 mL of I.S. solution (100 µg/mL) by sonication for 20 min at 30 °C. The samples were filtered through 45 µm nylon syringe filters. An aliquot of 10 μL of each sample was injected into the HPLC-PDA. All analyses were performed in triplicate.

3.7. GC/MS Analysis of Terpenes

The terpene profile was determined using the previously validated GC-MS method according to the following conditions [41]. The used chromatographic and mass spectrometric conditions are shown in Table 5.

Table 5.

GC/FID parameters for the analysis of cannabis terpenes.

Parameter Description
Instrument/
Software
Agilent 7890A series (Agilent) GC. Software (NIST)
(Version 2.0f; Standard Reference Data Program of the National Institute of
Standards and Technology, as distributed by Agilent Technologies).
Column DB-5MS capillary column (30 m × 0.25 mm I.D., 0.25 µm film thickness; Agilent).
Carrier gas Helium; flow rate of 1 mL/min.
Inlet temperature/
Split mode
250 °C/split ratio 15:1.
Injection volume 2 µL.
Temperature
program
The temperature program initiated at 50 °C (held for 2 min),
then increased to 85 °C at a rate of 2 °C/min, followed by a ramp to 165 °C at 3 °C/min.
Post-run, the temperature was held at 280 °C for 10 min.
Mass conditions Full scan mode; from 40 to 450 atomic mass units (amu).
The ionization energy = 70 eV. Ion source temperature = 230 °C.
Quadrupole temperature = 150 °C. Solvent delay was set to 4 min.
Transfer line temperature was 280 °C. Total run time was 56.16 min.

Preparation of Standard and Sample Solutions for the Analysis of Major Terpenes

A stock standard solution of each terpene (α-pinene, β-pinene, myrcene, d-limonene, terpinolene, linalool, α-terpineol, β-caryophyllene, α-humulene, and caryophyllene oxide) was prepared in ethyl acetate. The standard terpenes were mixed, and the concentration of each terpene was adjusted to be 1.0 mg/mL, from which, serial dilutions were made to prepare the individual points of the calibration curves. Five calibration points ranging from 0.75 to 100 µg/mL were prepared from the previously mentioned stock standard solutions and IS (100 µg/mL).

Samples from three chemovars of C. sativa (high THC chemovar, THC/CBD chemovar, and high CBD chemovar) were dried for 24 h at 40 °C in a ventilated oven and then ground in a stainless-steel coffee grinder. Triplicates (1.0 g each) of the powdered samples were weighed in a 15 mL centrifuge tube, and each was extracted with 10 mL of the extraction solution (100 µg/mL of n-tridecane as the IS in ethyl acetate) by sonication for 15 min. The mixture was centrifuged for 5 min at 1252× g, and the supernatants (without filtration) were used for the GC/MS analysis.

3.8. Determination of Moisture Content

The moisture content of biomass is critical to the quality of stored cannabis plant material as excessive moisture promotes the growth of mold. Moisture content was measured for all 33-barrel lots in triplicate using a validated Loss on Drying (LoD) method [38].

3.9. Statistical Analysis

In this study, a paired t-test was conducted to compare the mean concentrations of cannabinoids and terpenes before and after gamma irradiation. The null hypothesis (H0) stated that there is no significant difference in the concentrations, while the alternative hypothesis (H1) posited the presence of a significant difference. A paired t-test was chosen due to its suitability for comparing paired data. The test was executed using the ‘paired t-test’ function in JASP software (version 0.18.1.0) with a significance level of α = 0.05.

4. Conclusions

The results suggest that the gamma irradiation treatment of bulk cannabis plant material does not significantly affect their chemical or physical properties but does effectively reduce microbial contamination to levels considered safe for human use. Although gamma irradiation treatment is practical for the decontamination of large quantities of materials, other technologies such as X-ray irradiation may be considered for smaller quantities of cannabis. Upon irradiation, cannabinoids, terpenes, and moisture content were not changed by the irradiation treatment.

Author Contributions

Conceptualization, M.A.E. (Mahmoud A. ElSohly) and M.M.R.; methodology, C.G.M., E.A.I., M.A.E. (Mostafa A. Elhendawy), D.S. and A.S.W.; software, C.G.M., E.A.I., and M.A.E. (Mostafa A. Elhendawy); formal analysis, E.A.I. and C.G.M.; investigation, M.A.E. (Mahmoud A. ElSohly), M.A.E. (Mostafa A. Elhendawy), A.S.W., S.C. and M.M.R.; data curation, M.M.R., S.C., M.A.E. (Mostafa A. Elhendawy), C.G.M. and E.A.I.; writing—original draft preparation, M.M.R. and D.S.; writing—review and editing, M.A.E. (Mahmoud A. ElSohly), M.M.R., A.S.W., S.C. and D.S.; visualization, A.S.W. and S.C.; supervision, M.A.E. (Mahmoud A. ElSohly) and M.M.R.; project administration, M.A.E. (Mahmoud A. ElSohly); resources, D.S.; funding acquisition, M.A.E. (Mahmoud A. ElSohly). All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

Funding Statement

This research was partially funded by the National Institute on Drug Abuse, contract #N01DA-15-7793.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Russo E.B. History of cannabis and its preparations in saga, science, and sobriquet. Chem. Biodivers. 2007;4:1614–1648. doi: 10.1002/cbdv.200790144. [DOI] [PubMed] [Google Scholar]
  • 2.Andre C.M., Hausman J.F., Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front. Plant Sci. 2016;7:19. doi: 10.3389/fpls.2016.00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Small E. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Bot. Rev. 2015;81:189–294. doi: 10.1007/s12229-015-9157-3. [DOI] [Google Scholar]
  • 4.Crini G., Lichtfouse E., Chanet G., Morin-Crini N. Applications of hemp in textiles, paper industry, insulation and building materials, horticulture, animal nutrition, food and beverages, nutraceuticals, cosmetics and hygiene, medicine, agrochemistry, energy production and environment: A review. Environ. Chem. Lett. 2020;18:1451–1476. doi: 10.1007/s10311-020-01029-2. [DOI] [Google Scholar]
  • 5.Salami S.A., Martinelli F., Giovino A., Bachari A., Arad N., Mantri N. It is our turn to get cannabis high: Put cannabinoids in food and health baskets. Molecules. 2020;25:4036. doi: 10.3390/molecules25184036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zandkarimi F., Decatur J., Casali J., Gordon T., Skibola C., Nuckolls C. Comparison of the cannabinoid and terpene profiles in commercial cannabis from natural and artificial cultivation. Molecules. 2023;28:833. doi: 10.3390/molecules28020833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Korus J., Witczak M., Ziobro R., Juszczak L. Hemp (Cannabis sativa subsp. sativa) flour and protein preparation as natural nutrients and structure forming agents in starch based gluten-free bread. LWT. 2017;84:143–150. doi: 10.1016/j.lwt.2017.05.046. [DOI] [Google Scholar]
  • 8.Burczyk H., Grabowska L., Kołodziej J., Strybe M. Industrial hemp as a raw material for energy production. J. Ind. Hemp. 2008;13:37–48. doi: 10.1080/15377880801898717. [DOI] [Google Scholar]
  • 9.Casas X.A., Rieradevall i Pons J. Environmental analysis of the energy use of hemp–Analysis of the comparative life cycle: Diesel oil vs. hemp–diesel. Int. J. Agric. Resour. Gov. Ecol. 2005;4:133–139. doi: 10.1504/IJARGE.2005.007195. [DOI] [Google Scholar]
  • 10.Flores-Sanchez I.J., Verpoorte R. Secondary metabolism in cannabis. Phytochem. Rev. 2008;7:615–639. doi: 10.1007/s11101-008-9094-4. [DOI] [Google Scholar]
  • 11.Livingston S.J., Quilichini T.D., Booth J.K., Wong D.C., Rensing K.H., Laflamme-Yonkman J., Castellarin S.D., Bohlmann J., Page J.E., Samuels A.L. Cannabis glandular trichomes alter morphology and metabolite content during flower maturation. Plant J. 2020;101:37–56. doi: 10.1111/tpj.14516. [DOI] [PubMed] [Google Scholar]
  • 12.Chauhan M.S., Karat M., Binorkar S., Lambat R.A. Review on Mechanism, Therapeutic Uses and Pharmacological Activities of Cannabis sativa. Acta Sci. Med. Sci. 2022;6:8. doi: 10.31080/ASMS.2022.06.1337. [DOI] [Google Scholar]
  • 13.Russo E., Mathre M.L., Byrne A., Velin R., Bach P.J., Sanchez-Ramos J., Kirlin K.A. Chronic Cannabis Use in the Compassionate Investigational New Drug Program. J. Cannabis Ther. 2002;2:3–57. doi: 10.1300/J175v02n01_02. [DOI] [Google Scholar]
  • 14.Grotenhermen F. Cannabinoids and the endocannabinoid system. Cannabinoids. 2006;1:10–14. [Google Scholar]
  • 15.Mostafaei D.M., Ebadi A., Peirovi A., Taylor G., Salami S.A. THC and CBD Fingerprinting of an Elite Cannabis Collection from Iran: Quantifying Diversity to Underpin Future Cannabis Breeding. Plants. 2022;11:129. doi: 10.3390/plants11010129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cundell T. Microbiological attributes of powdered cannabis. Am. Pharm. Rev. Jul 31, 2015. [(accessed on 14 December 2022)]. Available online: https://www.americanpharmaceuticalreview.com/Featured-Articles/177487-Microbiological-Attributes-of-Powdered-Cannabis/
  • 17.McKernan K., Spangler J., Helbert Y., Lynch R.C., Devitt-Lee A., Zhang L., Orphe W., Warner J., Foss T., Hudalla C.J., et al. Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests. F1000Research. 2016;5:2471. doi: 10.12688/f1000research.9662.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ruchlemer R., Amit-Kohn M., Raveh D., Hanuš L. Inhaled medicinal cannabis and the immunocompromised patient. Support. Care Cancer. 2015;23:819–822. doi: 10.1007/s00520-014-2429-3. [DOI] [PubMed] [Google Scholar]
  • 19.Bal A., Agarwal A.N., Das A., Suri V., Varma S. Chronic necrotising pulmonary aspergillosis in a marijuana addict: A new cause of amyloidosis. Pathology. 2010;42:197–200. doi: 10.3109/00313020903493997. [DOI] [PubMed] [Google Scholar]
  • 20.Taylor D.N., Wachsmuth I.K., Shangkuan Y.-H., Schmidt E.V., Barrett T.J., Schrader J.S., Scherach C.S., McGee H.B., Feldman R.A., Brenner D.J. Salmonellosis associated with marijuana: A multistate outbreak traced by plasmid fingerprinting. N. Engl. J. Med. 1982;306:1249–1253. doi: 10.1056/NEJM198205273062101. [DOI] [PubMed] [Google Scholar]
  • 21.Health DDoE Special Concerns Associated with Marijuana Extractions, Concentrations, Infusions, and Infused Foods. [(accessed on 30 August 2022)]. Available online: https://www.denvergov.org/content/dam/denvergov/Portals/771/documents/PHI/Food/SpecialConcerns_AssociatedwithCannabisExtractions.pdf.
  • 22.Legare C.A., Raup-Konsavage W.M., Vrana K.E. Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology. 2022;107:131–149. doi: 10.1159/000521683. [DOI] [PubMed] [Google Scholar]
  • 23.U.S. Drug Enforcement Agency Drug Scheduling. [(accessed on 30 August 2022)]; Available online: https://www.dea.gov/drug-scheduling.
  • 24.National Conference of State Legislatures Cannabis Overview. [(accessed on 25 December 2022)]. Available online: https://www.ncsl.org/civil-and-criminal-justice/cannabis-overview.
  • 25.National Conference of State Legislatures, State Medical Cannabis Laws National Conference of State Legislatures. 2022. [(accessed on 25 December 2022)]. Available online: https://www.ncsl.org/health/state-medical-cannabis-laws.
  • 26.FDA Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry. [(accessed on 25 April 2023)]; Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cannabis-and-cannabis-derived-compounds-quality-considerations-clinical-research-guidance-industry.
  • 27.Carroll L. One in Seven U.S. Adults Used Marijuana in 2017. [(accessed on 25 April 2023)]. Available online: https://www.reuters.com/article/us-health-marijuna-us-adults/one-in-seven-u-s-adults-used-marijuana-in-2017-idUSKCN1LC2B7.
  • 28.Diehl J.F. Safety of Irradiated Foods. 2nd ed. CRC Press; New York, NY, USA: 1995. Radiation Sources and Process Control; p. 27. [Google Scholar]
  • 29.Hazekamp A. Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis. Front. Pharmacol. 2016;7:108. doi: 10.3389/fphar.2016.00108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jerushalmi S., Maymon M., Dombrovsky A., Freeman S. Effects of cold plasma, gamma and e-beam irradiations on reduction of fungal colony forming unit levels in medical cannabis inflorescences. J. Cannabis Res. 2020;2:12. doi: 10.1186/s42238-020-00020-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sterigenics General Guide to Gamma Irradiation. [(accessed on 9 August 2022)]. Available online: https://sterigenics.com/technologies/gamma-irradiation/?gclid=EAIaIQobChMIyOLCot-6-QIVBidMCh3IDQD0EAAYAiAAEgJz2_D_BwE.
  • 32.da Silva Aquino K.A. Sterilization by gamma irradiation. In: Adrovic F., editor. Gamma Radiation. InTech; Vienna, Austria: 2012. pp. 171–206. [Google Scholar]
  • 33.Andress E.L., Delaplane K.S., Schuler G.A. Food Irradiation. University of Florida Cooperative Extension Service, Institute of Food and Agricultural Sciences; Gainesville, FL, USA: 1998. pp. 1–11. [Google Scholar]
  • 34.Kovacs E., Keresztes A. Effect of gamma and UV-B/C radiation on plant cells. Micron. 2002;33:199–210. doi: 10.1016/S0968-4328(01)00012-9. [DOI] [PubMed] [Google Scholar]
  • 35.Emovon E. Keynote Address: Symposium Irradiation for National Development. Shelda Science and Technology Complex, SHESTCO; Abuja, Nigeria: 1996. [Google Scholar]
  • 36.Radwan M.M., Chandra S., Gul S., ElSohly M.A. Cannabinoids, phenolics, terpenes and alkaloids of cannabis. Molecules. 2021;26:2774. doi: 10.3390/molecules26092774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.USP Convention General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. USP 42–NF 37. [(accessed on 9 December 2022)]. Available online: https://www.usp.org/sites/default/files/usp/document/harmonization/gen-method/q05b_pf_ira_34_6_2008.pdf.
  • 38.Sarma N.D., Waye A., ElSohly M.A., Brown P.N., Elzinga S., Johnson H.E., Marles R.J., Melanson J.E., Russo E., Deyton L. Cannabis inflorescence for medical purposes: USP considerations for quality attributes. J. Nat. Prod. 2020;83:1334–1351. doi: 10.1021/acs.jnatprod.9b01200. [DOI] [PubMed] [Google Scholar]
  • 39.Gul W., Gul S.W., Radwan M.M., Wanas A.S., Mehmedic Z., Khan I.I., Sharaf M.H.M., El Sohly M.A. Determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. J. AOAC Int. 2015;98:1523–1528. doi: 10.5740/jaoacint.15-095. [DOI] [PubMed] [Google Scholar]
  • 40.Mehmedic Z., Chandra S., Slade D., Denham H., Foster S., Patel A.S., Ross S.A., Khan I.A., ElSohly M.A. Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J. Forensic Sci. 2010;55:1209–1217. doi: 10.1111/j.1556-4029.2010.01441.x. [DOI] [PubMed] [Google Scholar]
  • 41.Ibrahim E.A., Wang M., Radwan M.M., Wanas A.S., Majumdar C.G., Avula B., Wang Y.-H., Khan I.A., Chandra S., Lata H. Analysis of terpenes in Cannabis sativa L. using GC/MS: Method development, validation, and application. Planta Med. 2019;85:431–438. doi: 10.1055/a-0828-8387. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data are contained within the article.


Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES